SINONASAL SQUAMOUS CELL CARCINOMA
Clinical trials for SINONASAL SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new SINONASAL SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for SINONASAL SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug combo aims to shrink tumors before surgery, possibly sparing organs
Disease control Recruiting nowThis study is testing if adding an immunotherapy drug called cemiplimab to standard chemotherapy before surgery works better than chemotherapy alone for a type of head and neck cancer. It aims to see if the combination can better shrink tumors, improve survival, and potentially h…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
New drug combo aims to spare cancer patients from disfiguring surgery
Disease control Recruiting nowThis study is testing a new approach for people with advanced head and neck cancer. The goal is to see if giving a combination of chemotherapy and immunotherapy before surgery can shrink tumors enough to allow surgeons to perform less extensive operations. This could help patient…
Matched conditions: SINONASAL SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Disease control
Last updated Apr 02, 2026 14:57 UTC